Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LFT
2851
Lument Finance Trust
LFT
$121M
| $425K | ﹤0.01% |
182,544
+153,744
| +534% | +$358K |
|
|
BFX
2852
DELISTED
BowFlex Inc.
BFX
| $422K | ﹤0.01% |
547,900
+23,300
| +4% | +$17.9K |
|
2853
Crinetics Pharmaceuticals
CRNX
$3.2B
| $416K | ﹤0.01% |
11,700
-152,000
| -93% | -$5.4M |
|
2854
Werewolf Therapeutics
HOWL
$65.4M
| $415K | ﹤0.01% |
107,506
+62,306
| +138% | +$241K |
|
|
ADTH
2855
DELISTED
AdTheorent Holding Company, Inc. Common Stock
ADTH
| $415K | ﹤0.01% |
286,210
+10,310
| +4% | +$14.9K |
|
2856
iShares Morningstar Growth ETF
ILCG
$3B
| $414K | ﹤0.01% |
+6,100
| New | +$414K |
|
2857
Smith Micro Software
SMSI
$14.7M
| $414K | ﹤0.01% |
62,688
-46,850
| -43% | -$309K |
|
2858
First Trust Financials AlphaDEX Fund
FXO
$2.26B
| $411K | ﹤0.01% |
+9,500
| New | +$411K |
|
2859
Sanara MedTech
SMTI
$302M
| $411K | ﹤0.01% |
10,000
+1,200
| +14% | +$49.3K |
|
2860
Better Online Solutions
BOSC
$29.9M
| $410K | ﹤0.01% |
155,311
+6,198
| +4% | +$16.4K |
|
2861
Solitario Resources
XPL
$70.3M
| $409K | ﹤0.01% |
730,172
-8,899
| -1% | -$4.99K |
|
|
TCS
2862
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $409K | ﹤0.01% |
11,960
+10,120
| +550% | +$346K |
|
2863
Emerson Radio
MSN
$8.89M
| $409K | ﹤0.01% |
743,188
-12,700
| -2% | -$6.99K |
|
2864
Intellia Therapeutics
NTLA
$1.23B
| $408K | ﹤0.01% |
+13,397
| New | +$408K |
|
2865
Vince Holding
VNCE
$34M
| $407K | ﹤0.01% |
117,650
-2,700
| -2% | -$9.34K |
|
|
CGC
2866
Canopy Growth
CGC
$427M
| $406K | ﹤0.01% |
79,308
+68,582
| +639% | +$351K |
|
2867
ECB Bancorp
ECBK
$143M
| $406K | ﹤0.01% |
32,300
+15,800
| +96% | +$199K |
|
2868
Jasper Therapeutics
JSPR
$39.5M
| $406K | ﹤0.01% |
51,432
+20,411
| +66% | +$161K |
|
|
SACH
2869
Sachem Capital Corp
SACH
$62M
| $405K | ﹤0.01% |
+108,275
| New | +$405K |
|
|
IRS
2870
IRSA Inversiones y Representaciones
IRS
$906M
| $402K | ﹤0.01% |
48,432
-17,150
| -26% | -$142K |
|
2871
iShares US Utilities ETF
IDU
$1.6B
| $400K | ﹤0.01% |
+5,000
| New | +$400K |
|
2872
Sight Sciences
SGHT
$181M
| $399K | ﹤0.01% |
77,400
+11,400
| +17% | +$58.8K |
|
2873
Red River Bancshares
RRBI
$432M
| $398K | ﹤0.01% |
7,100
+1,500
| +27% | +$84.1K |
|
|
PDM
2874
Piedmont Realty Trust, Inc.
PDM
$1.1B
| $397K | ﹤0.01% |
55,800
-395,500
| -88% | -$2.81M |
|
2875
Century Therapeutics
IPSC
$43.3M
| $396K | ﹤0.01% |
119,200
+31,500
| +36% | +$105K |
|